Literature DB >> 28541194

Reduction of Blood Glucose Measurements to Calibrate Subcutaneous Glucose Sensors: A Bayesian Multiday Framework.

Giada Acciaroli, Martina Vettoretti, Andrea Facchinetti, Giovanni Sparacino, Claudio Cobelli.   

Abstract

OBJECTIVE: In most continuous glucose monitoring (CGM) devices used for diabetes management, the electrical signal measured by the sensor is transformed to glucose concentration by a calibration function whose parameters are estimated using self-monitoring of blood glucose (SMBG) samples. The calibration function is usually a linear model approximating the nonlinear relationship between electrical signal and glucose concentration in certain time intervals. Thus, CGM devices require frequent calibrations, usually twice a day. The aim here is to develop a new method able to reduce the frequency of calibrations.
METHODS: The algorithm is based on a multiple-day model of sensor time-variability with second-order statistical priors on its unknown parameters. In an online setting, these parameters are numerically determined by the Bayesian estimation exploiting SMBG sparsely collected by the patient. The method is assessed retrospectively on 108 CGM signals acquired for 7 days by the Dexcom G4 Platinum sensor, testing progressively less-calibration scenarios.
RESULTS: Despite the reduction of calibration frequency (on average from 2/day to 0.25/day), the method shows a statistically significant accuracy improvement compared to manufacturer calibration, e.g., mean absolute relative difference when compared to a laboratory reference decreases from 12.83% to 11.62% (p-value of 0.006).
CONCLUSION: The methodology maintains (sometimes improves) CGM sensor accuracy compared to that of the original manufacturer, while reducing the frequency of calibrations. SIGNIFICANCE: Reducing the need of calibrations facilitates the adoption of CGM technology both in terms of ease of use and cost, an obvious prerequisite for its use as replacement of traditional SMBG devices.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28541194     DOI: 10.1109/TBME.2017.2706974

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  7 in total

1.  Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear.

Authors:  Gregory P Forlenza; Taisa Kushner; Laurel H Messer; R Paul Wadwa; Sriram Sankaranarayanan
Journal:  Diabetes Technol Ther       Date:  2019-02-28       Impact factor: 6.118

2.  A Neural-Network-Based Approach to Personalize Insulin Bolus Calculation Using Continuous Glucose Monitoring.

Authors:  Giacomo Cappon; Martina Vettoretti; Francesca Marturano; Andrea Facchinetti; Giovanni Sparacino
Journal:  J Diabetes Sci Technol       Date:  2018-03

3.  Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications.

Authors:  Martina Vettoretti; Giacomo Cappon; Giada Acciaroli; Andrea Facchinetti; Giovanni Sparacino
Journal:  J Diabetes Sci Technol       Date:  2018-05-22

Review 4.  Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives.

Authors:  Giada Acciaroli; Martina Vettoretti; Andrea Facchinetti; Giovanni Sparacino
Journal:  Biosensors (Basel)       Date:  2018-03-13

5.  Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials.

Authors:  Patrick Schrangl; Florian Reiterer; Lutz Heinemann; Guido Freckmann; Luigi Del Re
Journal:  Biosensors (Basel)       Date:  2018-05-18

6.  Development of an Error Model for a Factory-Calibrated Continuous Glucose Monitoring Sensor with 10-Day Lifetime.

Authors:  Martina Vettoretti; Cristina Battocchio; Giovanni Sparacino; Andrea Facchinetti
Journal:  Sensors (Basel)       Date:  2019-12-03       Impact factor: 3.576

Review 7.  Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments.

Authors:  Omar Diouri; Monika Cigler; Martina Vettoretti; Julia K Mader; Pratik Choudhary; Eric Renard
Journal:  Diabetes Metab Res Rev       Date:  2021-03-24       Impact factor: 4.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.